Advertisement

Clinical Rheumatology

, Volume 38, Issue 2, pp 535–543 | Cite as

Active tuberculosis in patients with systemic lupus erythematosus from Southern China: a retrospective study

  • Minxi Lao
  • Dongying Chen
  • Xiangni Wu
  • Haihong Chen
  • Qian Qiu
  • Xiuyan Yang
  • Zhongping ZhanEmail author
Original Article

Abstract

To investigate the characteristics and associated factors for Mycobacterium tuberculosis (TB) infection in patients with systemic lupus erythematosus (SLE) from Southern China. A retrospective study of 1108 patients admitted to the First Affiliated Hospital of Sun Yat-Sen University from January 2007 to December 2017 was performed. Demographic and clinical characteristics, laboratory data, and radiographic manifestations were recorded. A total of 59 (5.3%) lupus patients with active TB were included. Pulmonary TB occurred in 41 (69.5%) patients. Single lobe involvement was showed in 14 (34.1%) patients. Multi-lobar involvement, including miliary TB (36.6%), was presented in 27 (65.8%) patients. Lower lobe involvement accounted for 31 (75.6%) of the cases. Extrapulmonary TB occurred in 18 (30.5%) patients. Nearly one-third (35.6%) of the patients developed disseminated TB. T-SPOT.TB assay was performed in 23 patients and positive in 18 patients (78.3%). Nineteen patients (32.2%) had co-infection with TB and other pathogens, most of which were bacterial-associated (52.6%). Lymphopenia was predominant in TB-infected patients, especially in those with disseminated TB. Multivariate logistic regression analysis found that lymphopenia [odds ratio (OR) = 2.19, 95% confidence interval (CI) 1.03–4.63, P = 0.04] and the accumulated doses of glucocorticoid (GC) (OR = 2.32, 95% CI 1.69–3.20, P < 0.001) were associated with TB. TB infection is a common comorbidity in patients with SLE. Manifestations of pulmonary computed tomography (CT) scan are relatively atypical. Co-infection with TB and other pathogens is not rare. Lymphopenia and the accumulated doses of GC are associated with TB infection in lupus patients.

Keywords

Co-infection Disseminated tuberculosis Lymphopenia Mycobacterium tuberculosis Systemic lupus erythematosus 

Notes

Funding

This project was supported by grants from the Guangdong Technology Project (2016A020215043) and grants from the National Natural Science Foundation of China (81603435, 81601403).

Compliance with ethical standards

Ethics committee of the First Affiliated Hospital of Sun Yat-sen University approved the research. This work was conducted according to the provisions of the Declaration of Helsinki.

Disclosures

None.

References

  1. 1.
    Fessler BJ (2002) Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 16(2):281–291CrossRefGoogle Scholar
  2. 2.
    Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, Cruz D, Depresseux G, Direskeneli H, Domènech I, Espinosa G, Fernández-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcìa-Carrasco M, García Iglesias MF, García-Tobaruela A, George J, Gil A, González-Santos P, Grana M, Gül A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M, Jedryka-Góral A, Khamashta MA, Lavilla P, Levi Y, López-Dulpa M, López-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perelló I, Petera P, Petrovic R, Piette JC, Pintado V, de Pita O, Popovic R, Pucci G, Puddu P, de Ramón E, Ramos-Casals M, Rodríguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgöz G, Urbano-Márquez A, Vasconcelos C, Vázquez JJ, Veronesi J, Vianna J, Vivancos J, European Working Party on Systemic Lupus Erythematosus (2006) Systemic lupuserythematosus in Europe at the change of the millennium: lessons from the BEuro-lupus project^. Autoimmun Rev 5(3):180–186CrossRefGoogle Scholar
  3. 3.
    Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 64(2):159–168CrossRefGoogle Scholar
  4. 4.
    GBD Tuberculosis Collaborators (2017) The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect Dis 18(3):261–284Google Scholar
  5. 5.
    Agrawal PN, Gupta D, Aggarwal AN, Behera D (2000) Incidence of tuberculosis among patients receiving treatment with oral corticosteroids. J Assoc Physicians India 48(9):881–884Google Scholar
  6. 6.
    Yang Y, Thumboo J, Tan BH, Tan TT, Fong CHJ, Ng HS, Fong KY (2017) The risk of tuberculosis in SLE patients from an Asian tertiary hospital. Rheumatol Int 37(6):1027–1033CrossRefGoogle Scholar
  7. 7.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725CrossRefGoogle Scholar
  8. 8.
    Kawai K, Villamor E, Mugusi FM, Saathoff E, Urassa W, Bosch RJ, Spiegelman D, Fawzi WW (2011) Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania. Int J Tuberc Lung Dis 15(10):1380–1389CrossRefGoogle Scholar
  9. 9.
    Kourbatova EV, Borodulin BE, Borodulina EA, del Rio C, Blumberg HM, Leonard MK Jr (2006) Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis 10(11):1224–1230Google Scholar
  10. 10.
    Ponce de León D, Acevedo-Vásquez E, Sánchez-Torres A, Cucho M, Alfaro J, Perich R, Pastor C, Harrison J, Sánchez-Schwartz C (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64(9):1360–1361CrossRefGoogle Scholar
  11. 11.
    Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, Drobniewski F, Lalvani A (2007) A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 11(3):1–196CrossRefGoogle Scholar
  12. 12.
    Drobniewski F, Caws M, Gibson A, Young D (2003) Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis 3(3):141–147CrossRefGoogle Scholar
  13. 13.
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640CrossRefGoogle Scholar
  14. 14.
    Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369CrossRefGoogle Scholar
  15. 15.
    Shang Q, Yip GW, Tam LS, Zhang Q, Sanderson JE, Lam YY, Li CM, Wang T, Li EK, Yu CM (2012) SLICC/ACR damage index independently associated with left ventricular diastolic dysfunction in patients with systemic lupus erythematosus. Lupus 21(10):1057–1062CrossRefGoogle Scholar
  16. 16.
    Yun JE, Lee SW, Kim TH, Jun JB, Jung S, Bae SC, Kim TY, Yoo DH (2002) The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20(2):127–132Google Scholar
  17. 17.
    Ling DI, Nicol MP, Pai M, Pienaar S, Dendukuri N, Zar HJ (2013) Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis. Thorax 68(9):860–866CrossRefGoogle Scholar
  18. 18.
    Metcalfe JZ, Cattamanchi A, Vittinghoff E, Ho C, Grinsdale J, Hopewell PC, Kawamura LM, Nahid P (2010) Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects. Am J Respir Crit Care Med 181(1):87–93CrossRefGoogle Scholar
  19. 19.
    Ramagopalan SV, Goldacre R, Skingsley A, Conlon C, Goldacre MJ (2013) Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med 11:97CrossRefGoogle Scholar
  20. 20.
    Meinerz G, da Silva CK, Goldani JC, Garcia VD, Keitel E (2016) Epidemiology of tuberculosis after kidney transplantation in a developing country. Transpl Infect Dis 18(2):176–182Google Scholar
  21. 21.
    Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, Borand L, Prak N, Kim C, Lak KK, Hak C, Dim B, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX, CAMELIA (ANRS 1295-CIPRA KH001) Study Team (2014) Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clin Infect Dis 59(3):435–445CrossRefGoogle Scholar
  22. 22.
    Chen D, Yang Z, Yang Y, Zhan Z, Yang X (2016) A rare case of disseminated tuberculosis of the bone marrow in systemic lupus erythematosus: case report. Medicine (Baltimore) 95(18):e3552CrossRefGoogle Scholar
  23. 23.
    Li JC, Fong W, Wijaya L, Leung YY (2018) Disseminated tuberculosis masquerading as a presentation of systemic lupus erythematosus. Int J Rheum Dis 21(1):352–355CrossRefGoogle Scholar
  24. 24.
    Kim JH, Langston AA, Gallis HA (1990) Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis 12(4):583–590CrossRefGoogle Scholar
  25. 25.
    Benito N, García-Vázquez E, Horcajada JP, González J, Oppenheimer F, Cofán F, Ricart MJ, Rimola A, Navasa M, Rovira M, Roig E, Pérez-Villa F, Cervera C, Moreno A (2015) Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect 21(7):651–658CrossRefGoogle Scholar
  26. 26.
    García-Goez JF, Linares L, Benito N, Cervera C, Cofán F, Ricart MJ, Navasa M, Pérez-Villa F, González J, Moreno A (2009) Tuberculosis in solid organ transplant recipients at a tertiary hospital in the last 20 years in Barcelona, Spain. Transplant Proc 41(6):2268–2270CrossRefGoogle Scholar
  27. 27.
    Ribeiro FM, Szyper-Kravitz M, Klumb EM, Lannes G, Ribeiro FR, Albuquerque EM, Shoenfeld Y (2010) Can lupus flares be associated with tuberculosis infection? Clin Rev Allergy Immunol 38(2–3):163–168CrossRefGoogle Scholar
  28. 28.
    Podlekareva DN, Efsen AM, Schultze A, Post FA, Skrahina AM, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Miro JM, Vassilenko A, Girardi E, Bruyand M, Obel N, Lundgren JD, Mocroft A, Kirk O, TB:HIV study group in EuroCoord (2016) Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. Lancet HIV 3(3):e120–e131CrossRefGoogle Scholar
  29. 29.
    González-Naranjo LA, Betancur OM, Alarcón GS, Ugarte-Gil MF, Jaramillo-Arroyave D, Wojdyla D, Pons-Estel GJ, Rondón-Herrera F, Vásquez-Duque GM, Quintana-López G, Da Silva NA, Tavares Brenol JC, Reyes-Llerena G, Pascual-Ramos V, Amigo MC, Massardo L, Alfaro-Lozano J, Segami MI, Esteva-Spinetti MH, Iglesias-Gamarra A, Pons-Estel BA (2016) Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: data from a multiethnic Latin American cohort. Semin Arthritis Rheum 45(6):675–683Google Scholar
  30. 30.
    Lieberman LA, Tsokos GC (2014) Lupus-prone mice fail to raise antigen-specific T cell responses to intracellular infection. PLoS One 9(10):e111382CrossRefGoogle Scholar
  31. 31.
    Leung DY, Bloom JW (2003) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 111(1):3–22Google Scholar
  32. 32.
    Pazirandeh A, Xue Y, Prestegaard T, Jondal M, Okret S (2002) Effects of altered glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis. FASEB J 16(7):727–729CrossRefGoogle Scholar
  33. 33.
    Skogmar S, Schön T, Balcha TT, Jemal ZH, Tibesso G, Björk J, Björkman P (2013) CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia. PLoS One 8(12):e83270CrossRefGoogle Scholar
  34. 34.
    Andersen AB, Range NS, Changalucha J, Praygod G, Kidola J, Faurholt-Jepsen D, Krarup H, Grewal HM, Friis H (2012) CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection. BMC Infect Dis 12:66CrossRefGoogle Scholar
  35. 35.
    Bold TD, Ernst JD (2012) CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J Immunol 189(5):2530–2536CrossRefGoogle Scholar
  36. 36.
    Boggiano C, Eichelberg K, Ramachandra L, Shea J, Ramakrishnan L, Behar S, Ernst JD, Porcelli SA, Maeurer M, Kornfeld H (2017) "the impact of Mycobacterium tuberculosis immune evasion on protective immunity: implications for TB vaccine design" - meeting report. Vaccine 35(27):3433–3440CrossRefGoogle Scholar
  37. 37.
    Kwan CK, Ernst JD (2011) HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 24(2):351–376CrossRefGoogle Scholar
  38. 38.
    Skogmar S, Schön T, Balcha TT, Jemal ZH, Tibesso G, Björk J, Björkman P (2013) CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia. PLoS One 16;8(12):e83270CrossRefGoogle Scholar
  39. 39.
    Al-Aska A, Al-Anazi AR, Al-Subaei SS, Al-Hedaithy MA, Barry MA, Somily AM, Buba F, Yusuf U, Al Anazi NA (2011) CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia. Eur J Med Res 16(6):285–288CrossRefGoogle Scholar
  40. 40.
    Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, Mitra DK (2009) FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med 179(11):1061–1070CrossRefGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2018

Authors and Affiliations

  1. 1.Department of Rheumatologythe First Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina
  2. 2.Department of GeriatricsThe First Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina
  3. 3.Department of RheumatologyBeijing Jishuitan HospitalBeijingChina
  4. 4.Department of RespirologyThe First Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina

Personalised recommendations